Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Assets: 2022-2024

Historic Assets for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Dec 2024 value amounting to $582.8 million.

  • Day One Biopharmaceuticals' Assets fell 14.49% to $513.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $513.8 million, marking a year-over-year decrease of 14.49%. This contributed to the annual value of $582.8 million for FY2024, which is 54.98% up from last year.
  • As of FY2024, Day One Biopharmaceuticals' Assets stood at $582.8 million, which was up 54.98% from $376.0 million recorded in FY2023.
  • In the past 5 years, Day One Biopharmaceuticals' Assets registered a high of $582.8 million during FY2024, and its lowest value of $349.1 million during FY2022.
  • For the 3-year period, Day One Biopharmaceuticals' Assets averaged around $436.0 million, with its median value being $376.0 million (2023).
  • Data for Day One Biopharmaceuticals' Assets shows a peak YoY spiked of 54.98% (in 2024) over the last 5 years.
  • Day One Biopharmaceuticals' Assets (Yearly) stood at $349.1 million in 2022, then rose by 7.73% to $376.0 million in 2023, then soared by 54.98% to $582.8 million in 2024.